Modèles transgéniques pour l'étude de la fonction ... - Epublications

Franke, T. F., Kaplan, D. R., Cantley, L. C. and Toker, A. (1997). Direct regulation of
the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275, 665-8.
Freeze, H. H. (2006). Genetic defects in the human glycome. Nat Rev Genet 7, 537-51.
Freeze, H. H. and Aebi, M. (2005). Altered glycan structures: the molecular basis of
congenital disorders of glycosylation. Curr Opin Struct Biol 15, 490-8.
Fruman, D. A., Snapper, S. B., Yballe, C. M., Alt, F. W. and Cantley, L. C. (1999).
Phosphoinositide 3-kinase knockout mice: role of p85alpha in B cell development and
proliferation. Biochem Soc Trans 27, 624-9.
Fukumori, T., Takenaka, Y., Yoshii, T., Kim, H. R., Hogan, V., Inohara, H.,
Kagawa, S. and Raz, A. (2003). CD29 and CD7 mediate galectin-3-induced type II T-cell
apoptosis. Cancer Res 63, 8302-11.
Fuxa, M., Skok, J., Souabni, A., Salvagiotto, G., Roldan, E. and Busslinger, M.
(2004). Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin
heavy-chain gene. Genes Dev 18, 411-22.
Fuxa, M. and Skok, J. A. (2007). Transcriptional regulation in early B cell development.
Curr Opin Immunol 19, 129-36.
Galceran, J., Farinas, I., Depew, M. J., Clevers, H. and Grosschedl, R. (1999). Wnt3a-
/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. Genes Dev 13, 709-17.
Gallagher, J. T., Lyon, M. and Steward, W. P. (1986). Structure and function of
heparan sulphate proteoglycans. Biochem J 236, 313-25.
Galvan, M., Tsuboi, S., Fukuda, M. and Baum, L. G. (2000). Expression of a specific
glycosyltransferase enzyme regulates T cell death mediated by galectin-1. J Biol Chem 275,
16730-7.
Gauthier, L., Rossi, B., Roux, F., Termine, E. and Schiff, C. (2002). Galectin-1 is a
stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between
pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci U S A 99, 13014-9.
Gavel, Y. and von Heijne, G. (1990). Sequence differences between glycosylated and
non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng
3, 433-42.
Gay, D., Saunders, T., Camper, S. and Weigert, M. (1993). Receptor editing: an
approach by autoreactive B cells to escape tolerance. J Exp Med 177, 999-1008.
Geha, R. S., Jabara, H. H. and Brodeur, S. R. (2003). The regulation of
immunoglobulin E class-switch recombination. Nat Rev Immunol 3, 721-32.
Geisow, M. J. (1991). The coming of age of glycobiology. Trends Biotechnol 9, 221-5.
Gellert, M. (2002). V(D)J recombination: RAG proteins, repair factors, and regulation.
Annu Rev Biochem 71, 101-32.
Giannini, S. L., Singh, M., Calvo, C. F., Ding, G. and Birshtein, B. K. (1993). DNA
regions flanking the mouse Ig 3' alpha enhancer are differentially methylated and DNAase I
hypersensitive during B cell differentiation. J Immunol 150, 1772-80.
Gold, M. R., Sanghera, J. S., Stewart, J. and Pelech, S. L. (1992). Selective activation
of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane
immunoglobulin cross-linking. Evidence for protein kinase C-independent and -dependent
mechanisms of activation. Biochem J 287 (Pt 1), 269-76.
Goodhardt, M., Cavelier, P., Doyen, N., Kallenbach, S., Babinet, C. and Rougeon, F.
(1993). Methylation status of immunoglobulin kappa gene segments correlates with their
recombination potential. Eur J Immunol 23, 1789-95.
Goodman, D. J., Gaff, C. and Gerondakis, S. (1993). The IL-4 induced increase in the
frequency of resting murine splenic B cells expressing germline Ig heavy chain gamma 1
transcripts correlates with subsequent switching to IgG1. Int Immunol 5, 199-208.
159